QUICK ANSWER

Before a veterinary vaccine bottle is approved for commercial filling, confirm the exact bottle/stopper/cap set, critical dimensions, sterilization condition, filling and closing-line fit, sample-lot traceability, and the customer's filled-product test plan. The packaging supplier can support component data and samples, but formulation compatibility, stability, final sterility assurance and regulatory approval remain the veterinary pharmaceutical company's responsibility.

Why This Packaging Trend Matters for Veterinary Vaccine Projects

The September 29 PCL announcement is not a veterinary-specific regulation or a new mandatory test. It is, however, a useful market signal: pharmaceutical companies and CDMOs increasingly expect packaging decisions to be supported by structured testing and documentation. For a veterinary vaccine project, approving a bottle only because it has the right nominal capacity or looks acceptable can leave important manufacturing risks unresolved.

FUDAPLASTIC currently lists plastic veterinary vaccine bottles from 10 mL to 500 mL. The range includes bottle configurations used with a rubber stopper and aluminum cap, with high-temperature/pressure or EO sterilization options stated on the product page. Those published specifications are a starting point for project selection—not a substitute for product-specific qualification.

1. Lock the Exact Bottle-Closure Configuration

Sample approval should identify the exact bottle reference, stopper and aluminum-cap combination, not just a nominal size such as “100 mL vaccine bottle.” If one component changes after testing, the approved package system has changed and the buyer should decide whether re-evaluation is required.

2. Define Critical Dimensions Around the Filling Process

Capacity alone is not enough. Neck inner and outer dimensions, bottle height and diameter, stopper fit and capping interface can affect feeding, filling, stoppering and crimping. Buyers should compare supplier drawings with the actual filling and closing equipment before pilot trials.

3. Confirm Sterilization Status Before the Trial

The buyer should confirm whether samples are supplied non-sterile, EO sterilized, or intended for another validated treatment route. The sterilization condition used for evaluation should reflect the planned process as closely as practical because processing can affect material and component performance.

4. Test the Bottle on the Real Filling and Closing Sequence

Manual filling can hide line-side problems. A useful pilot review should reproduce container feeding, filling, stopper placement, cap application, inspection and packing steps whenever possible. Record line conditions so results can be compared with future pilot and commercial batches.

5. Record Sample Lot, Acceptance Criteria and Change Triggers

Keep the sample lot or batch reference, approved drawing, visual standard, packing configuration and key acceptance results together. Define which changes—material source, mold, neck dimensions, closure, sterilization method, printing or packing—must trigger notification or requalification.

6. Separate Packaging-Supplier Data from Drug-Product Validation

The packaging supplier can provide samples, component specifications and available quality information. The veterinary drug manufacturer or its contract filler must establish formulation compatibility, stability in the proposed container-closure system, final sterility assurance, transport suitability and regulatory acceptability for the marketed product.

FUDAPLASTIC Vaccine Bottle Options

The current FUDAPLASTIC Vaccine Bottle page lists references from 10 mL to 500 mL, including multiple neck-size options. It also states rubber stopper + aluminum cap configurations, printing, sample support and customization. For an RFQ, the most useful information is the target capacity, filling volume, preferred bottle material, required neck/closure format, sterilization requirement, filling/capping equipment, sample quantity and destination market.

FAQ

Is a visually acceptable bottle sample enough for approval?

No. Commercial qualification should also cover the closure system, dimensions, sterilization condition, actual filling/closing process, documentation and product-specific testing.

Does FUDAPLASTIC determine vaccine compatibility or shelf life?

No. Final compatibility, stability, sterility assurance and regulatory suitability must be established by the veterinary pharmaceutical company or its authorized testing/contract manufacturing partners.

What should I send when requesting vaccine bottle samples?

Send target capacity and fill volume, material preference, neck/closure requirement, sterilization requirement, filling/capping information, target market, sample quantity and any critical dimensions or reference drawings.